Table 3 List of good surface accessibility peptides34.

From: Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2

No

Start

End

Peptide

Length

Antigenicity

Allergenicity

Toxicity

1

73

80

TNGTKRFD

8

0.2041

Allergen

Toxic

2

110

115

LDSKTQ

6

1.3071

Allergen

Toxic

3

179

185

LEGKQGN

7

1.8367

Non-allergen

Non-toxic

4

202

208

KIYSKHT

7

0.7773

Non-allergen

Non-toxic

5

250

255

TPGDSS

6

0.3268

Allergen

Toxic

6

278

284

KYNENGT

7

0.9414

Allergen

Toxic

7

352

357

AWNRKR

6

1.6320

Non-allergen

Non-toxic

8

419

428

ADYNYKLPDD

10

0.6956

Allergen

Toxic

9

437

442

NSNNLD

6

1.1859

Non-allergen

Non-toxic

10

455

468

LFRKSNLKPFERDI

14

0.3610

Allergen

Toxic

11

569

581

IADTTDAVRDPQT

13

0.3018

Allergen

Toxic

12

601

606

GTNTSN

6

1.2831

Non-allergen

Non-toxic

13

674

685

YQTQTNSPRRAR

12

0.0760

Non-allergen

Toxic

14

773

779

EQDKNTQ

7

0.1017

Allergen

Toxic

15

786

794

KQIYKTPPI

9

0.2705

Allergen

Toxic

16

808

817

DPSKPSKRSF

10

0.8148

Non-allergen

Toxic

17

1068

1076

VPAQEKNFT

9

1.0107

Non-allergen

Non-toxic

18

1105

1111

TQRNFYE

7

0.2190

Non-allergen

Toxic

19

1139

1162

DPLQPELDSFKEELDKYFKNHTSP

24

 − 0.3378

Non-allergen

Toxic

20

1179

1186

IQKEIDRL

8

 − 1.0253

Allergen

Toxic

21

1202

1210

ELGKYEQYI

9

0.5415

Allergen

Toxic

22

1256

1261

FDEDDS

6

 − 0.0685

Allergen

Toxic